Suchergebnisse - "François, P"

PubPharm (29)

1

Trastuzumab deruxtecan versus treatment of physician's choice in patients with HER2-positive metastatic breast cancer (DESTINY-Breast02) : patient-reported outcomes from a randomised, open-label, multicentre, phase 3 trial

enthalten in: The Lancet. Oncology | 2024

von Fehm, T. | Cottone, F. | Dunton, K. | +13

2

Paclitaxel plus Eftilagimod Alpha, a Soluble LAG-3 Protein, in Metastatic, HR+ Breast Cancer : Results from AIPAC, a Randomized, Placebo Controlled Phase IIb Trial

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2024

von Wildiers, H. | Armstrong, A. | Cuypere, E. | +17

3

Paclitaxel plus carboplatin and durvalumab with or without oleclumab for women with previously untreated locally advanced or metastatic triple-negative breast cancer : the randomized SYNERGY phase I/II trial

enthalten in: Nature communications | 2023

von Buisseret, L. | Loirat, D. | Aftimos, P. | +33

ErratumIn: Nat Commun. 2023 Dec 12;14(1):8223. - PMID 38086864

4

Trastuzumab deruxtecan versus treatment of physician's choice in patients with HER2-positive metastatic breast cancer (DESTINY-Breast02) : a randomised, open-label, multicentre, phase 3 trial

enthalten in: Lancet (London, England) | 2023

von André, F. | Hee Park, Y. | Kim, S. | +25

CommentIn: Lancet. 2023 May 27;401(10390):1746-1747. - PMID 37086743

5

Treatment With Etirinotecan Pegol for Patients With Metastatic Breast Cancer and Brain Metastases : Final Results From the Phase 3 ATTAIN Randomized Clinical Trial

enthalten in: JAMA oncology | 2022

von Tripathy, D. | Tolaney, S. | Seidman, A. | +74

6

Survival outcomes after neoadjuvant letrozole and palbociclib versus third generation chemotherapy for patients with high-risk oestrogen receptor-positive HER2-negative breast cancer

enthalten in: European journal of cancer (Oxford, England : 1990) | 2022

von Delaloge, S. | Dureau, S. | D'Hondt, V. | +19

7

The effects of experimentally manipulated social status and subjective social status on physical activity among Hispanic adolescents : An RCT

enthalten in: Pediatric obesity | 2022

von Lee, A. | Huo, T. | Miller, D. | +6

8

A Randomized Phase II Study of Anti-CSF1 Monoclonal Antibody Lacnotuzumab (MCS110) Combined with Gemcitabine and Carboplatin in Advanced Triple-Negative Breast Cancer

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2022

von Kuemmel, S. | Campone, M. | Loirat, D. | +25

9

Identification of Milk and Cheese Intake Biomarkers in Healthy Adults Reveals High Interindividual Variability of Lewis System-Related Oligosaccharides

enthalten in: The Journal of nutrition | 2020

von Pimentel, G. | Burnand, D. | Münger, L. | +4

10

Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer

enthalten in: The New England journal of medicine | 2020

von Murthy, R. | Loi, S. | Okines, A. | +29

ErratumIn: N Engl J Med. 2020 Feb 6;382(6):586. - PMID 31881136